the objective of the current study is to compare the clinical effectiveness and toxicity of prednimustine with its components of chlorambucil plus prednisolone , and to compare the clinical effectiveness and toxicity of a continuous treatment with an intermittent one .
C0032949
prednimustine
C0008163
chlorambucil